With the move in May 2017 to the new head offices of Celesio AG in the Europaviertel district in Stuttgart, 380 employees – who were previously spread across five sites – will be brought together on one site. Through the move from Bad Cannstatt to the EuropePlaza, which is close to the main train station, the pharmaceuticals distributor is improving its accessibility by public transport considerably. This is why the focus of the mobility concept is on its funding: Celesio is subsidising the Stuttgart public transport company ticket and is making employee parking spaces subject to charge. The company is also testing electric company cars and is providing fast-charging stations.
Another important element on the path to sustainable employee mobility is the provision of covered bicycle stands as well as changing rooms, lockers and showers at the future site.
The new building also demonstrates the dedication of the Stuttgart-based company towards sustainability as it has been awarded a Gold certification for its energy-efficient, environmentally-friendly design in accordance with the standards of the Deutsche Gesellschaft für Nachhaltiges Bauen (DGNB, The German Sustainable Building Council).
About the Celesio Group
Celesio is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sector. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care.
With strong brands and about 36,000 employees, the group is active in 13 European countries (thereof with own operations in ten countries; Celesio manages operations in two countries and participates in one country in a joint venture). Every day, the company serves over 2 million customers – at more than 2,150 pharmacies of its own, at about 300 managed pharmacies and at over 5,500 participants in the brand partnership schemes. With 109 wholesale branches in Europe, Celesio supplies more than 50,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products.
McKesson Corporation, San Francisco, USA, is the majority shareholder in Celesio AG. The company acquired more than 75 percent of Celesio AG shares in February 2014. McKesson provides solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services.